Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2

Area of Science:

• Genomics
• Cancer Genetics
• Molecular Oncology

Background:

• Interpreting complex somatic mutation patterns from exome sequencing is challenging.
• Identifying the relevance of individual mutations requires advanced analytical approaches.
• Chromosomal aberrations are common in myeloid malignancies, but their target genes are not always clear.

Purpose of the Study:

• To develop and apply an approach combining exome sequencing and SNP microarray data to identify targets of chromosomal aberrations in myeloid malignancies.
• To investigate the role of chromosome 11 in myeloid malignancies by analyzing deletions, gains, and uniparental disomies (UPDs).
• To identify potential tumor suppressor genes on chromosome 11 affected by mutations and chromosomal alterations.

Main Methods:

• Analysis of 813 samples from 773 patients with myeloid malignancies using SNP microarrays.
• Exome sequencing was performed on selected cases with chromosome 11 defects.
• Statistical analysis to associate chromosomal aberrations with specific mutations and clinical outcomes (e.g., acute myeloid leukemia).

Main Results:

• Chromosome 11 aberrations (gains, losses, UPDs) were identified in 6.4% of samples.
• Chromosome 11q UPDs were frequently associated with CBL mutations.
• A common deleted region on chromosome 11 was linked to de novo acute myeloid leukemia (P=0.013).
• Evidence suggests LMO2 may function as a tumor suppressor targeted by 11p deletions.

Conclusions:

• The integrated approach of exome sequencing and SNP microarray data effectively identifies targets of chromosomal aberrations.
• Chromosome 11 plays a significant and complex role in myeloid malignancies, harboring multiple tumor suppressor genes.
• Further investigation into chromosome 11 alterations is crucial for understanding myeloid leukemia pathogenesis.